Company

Patrys Ltd

ASX:PAB

Based in Melbourne, Australia, Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different indications.

68 stories · page 4 of 4

Pharma & Biotech

Patrys' multiple myeloma clinical trial reports positive safety data

By Proactive 07/03/2013

Pharma & Biotech

Patrys given nod to advance bone marrow cancer trial

By Proactive 14/01/2013

Pharma & Biotech

Patrys enrols first patient in bone marrow cancer trial

By Proactive 07/11/2012

Pharma & Biotech

Patrys adds Australia to bone marrow cancer trial

By Proactive 01/11/2012

Pharma & Biotech

Patrys given green light to begin bone marrow cancer trial

By Proactive 20/09/2012

Pharma & Biotech

Patrys secures long term market exclusivity for cancer treatment with U.S. patent

By Proactive 24/05/2012

Pharma & Biotech

Patrys reaffirms safety of anti-cancer treatment in melanoma trial

By Proactive 21/03/2012

Pharma & Biotech

Patrys’ anti-cancer drug shown to be safe in the treatment of melanoma

By Proactive 09/02/2012